Iodine and Potassium Iodide

I was revisiting the sites that deal with potassium iodide used for dermatoligic conditions and thought it might be useful to recap some of that material to see if there are some clues.

Potassium iodide

Potassium iodide (KI) is prepared by reacting iodine with a hot solution of potassium hydroxide. It is mainly used in the form of a saturated solution, 100gm of potassium iodide to 100ml of water. This equates to approximately 50mg/drop. The solution is usually added to water, fruit juice or milk before drinking.

Potassium iodide has been primarily used in the treatment and prevention of simple goitre, which is endemic in areas where the diet is deficient in iodides. Goitre results from low levels of thyroid hormone. Potassium iodide is usually given for this purpose as iodised salt. Other indications include treatment of hyperthyroidism, radiation protectant of the thyroid gland, pre-operative preparation of patients with Graves disease and the treatment of some dermatological conditions such as cutaneous lymphatic sporotrichosis and inflammatory dermatoses.

Potassium iodide for dermatological diseases

It is not clear how potassium idodide works in the treatment of dermatological conditions but it may be because of its effect on neutrophils. Neutrophils are a type of white blood cell, important in the immune system's fight against bacteria.

Potassium iodide appears to be particularly effective in conditions where neutrophils predominate in the early stages of the disease. Its activity against fungi is possibly because it kills the fungi directly or by enhancement of the body's immunologic and non-immunologic defence mechanisms.

The effectiveness of potassium iodide in the treatment of dermatological diseases has been shown in a number of studies.

There is a table that lists conditions and dosage: http://dermnetnz.org/treatments/potassium-iodide.html

In some cases, it's 6 grams a day (!) for up to ten weeks!!!!

SOME people get side effects:

Side effects are rare when potassium iodide is used in short courses and at low doses. The most common side effects are abdominal pain, diarrhoea, nausea or vomiting. These acute side effects often go away during treatment as your body adjusts to the medicine or can be lessened by avoiding rapid dosage increases. Other, less common side effects include urticaria and angioedema, i.e. hives, swelling of arms, face, legs, lips, tongue, throat and lymph glands.

They say there can be issues with "prolonged use" at higher doses. Don't know what "prolonged" means since they've just said that some conditions need up to 10 weeks of treatment at very high doses!!!

With prolonged use, patients may experience symptoms of iodism or potassium toxicity.

Symptoms of iodism include:

Burning of mouth or throat
Metallic taste
Increased watering of mouth
Sore teeth and gums
Severe headache

Symptoms of potassium toxicity include:

Confusion
Irregular heartbeat
Numbness, tingling, pain or weakness in hands or feet

Following a link there is this:
http://dermnetnz.org/reactions/halogenodermas.html
Halogenodermas

What are halogenodermas?

Halogenodermas are rare skin reactions related to high levels of halogens in the body. Halogens are a group of natural elements with similar chemical properties. Examples of clinically relevant halogens are bromine and iodine, and when these are part of compounds, such as medications, they are called bromides and iodides. The skin eruption may be named for the specific halogen involved, i.e., bromoderma and iododerma respectively.

Who gets a halogenoderma?

Bromine and bromides

Bromides have been widely used orally as sedatives, anti-epileptics, anti-neoplastics (chemotherapy), spasmolytics (used for colic) and expectorants (cough medicine).

Bromide may still be prescribed in:

carbromalhydroxyzine hydrochloride (short acting sedative)
pipobroman (alkylating agent for myeloproliferative disorders, e.g., some types of leukaemia)
potassium bromide (for epilepsy)
ipratropium bromide (bronchodilator)
dextromethorphan hydrobromide (antitussive in cough mixtures)
scopolamine bromide (to treat colic in infants).

Bromoderma has been reported in breastfed infants when the mother was taking a bromine-containing medication.

Bromine intoxication may occur in 1-10% of exposed patients.

Citrus-flavoured soft drinks may contain brominated vegetable oil as an emulsifier and flavour carrier. Excessive consumption of cola drinks and ‘Ruby Red Squirt’ have been reported to cause bromoderma.

Other sources of bromine have included the pesticide methyl bromide, brominated spa pool disinfectants, flame retardants, permanent hair wave solutions and silver bromide used in photographic films/papers.


Iodine and iodides

Iodine is used topically, orally and by injection.

Iodine is commonly used in topical antiseptics and there have been rare reports of iododerma following prolonged use of iodine-containing antiseptics applied to large areas of broken skin, e.g., to burns and following surgery where the wound has been left open to heal.

Oral iodine is used in the treatment of some thyroid diseases, and potassium iodide for the skin diseases erythema nodosum and sporotrichosis. It is found in some expectorants, multivitamins and tonics.

Amiodarone, a medication used to treat angina and heart arrhythmias (palpitations), has rarely been reported to cause iododerma after 18-24 months use. Iodine may also be ingested in high-iodine containing foods such as seaweed, seafood and iodised salt, with rare cases of iododerma reported following prolonged and excessive ingestion.

Iodine is used as a radiocontrast medium for x-rays including CT scan, cholecystogram and pyelogram, either orally or by injection into the bloodstream. However most of the iodine administered this way would usually be excreted by the kidneys within 24 hours of administration.

The amount of iodine required to cause an iododerma reaction is variable.

Accumulation of the halogen in the body seems to be required for this reaction so it usually occurs with: –

prolonged or excessive use, and/or
acute or chronic kidney failure, as halogens are excreted from the body by the kidneys

A possible association has been suggested between halogenoderma and polyarteritis nodosa or myeloproliferative disorders such as multiple myeloma.

Clinical features

Generally, it takes months of continuous exposure to a halogen in order to develop a halogenoderma. However, in some cases it can be acute within days, particularly following administration of iodine-containing radiocontrast medium for x-rays in patients with kidney failure.

Lesions most commonly appear on the face and upper body, but involvement of the limbs and mucous membranes (mouth, conjunctiva of the eye) can also occur.

There are a number of clinical presentations of halogenodermas: –

Acne-like rash – pustules and small red lumps (acne medicamentosa)
Vegetating/fungating nodules – raised firm lumps
Exudative plaques – weepy, slightly raised, large areas
Vegetating or necrotic ulcer with pustules
Blisters – small or large; clear, pus- or blood-filled
Tuberous bromoderma – occurs mainly in infants and starts as small red bumps or pustules that rapidly merge into a raised plaque, most commonly on face, scalp and legs
Halogen panniculitis (inflammation of fat) – tender red swellings under the skin usually 1-2 cm in diameter, but can be up to 10 cm. Abscesses form that may ulcerate and scar. This is part of a systemic illness, initially with fever and diarrhoea, but with continued halogen exposure abdominal and muscle pain develop, as well as worsening of the initial symptoms.

More than one of these skin patterns may occur in an individual. Lesions such as ulcers and plaques may be solitary or multiple.

Swelling of the major salivary glands (parotid, submandibular) has been reported following iodine-containing contrast medium and has been called ‘iodine mumps’.

Rarely there may also be systemic symptoms and signs of halogen toxicity. Bromism includes muscle weakness, personality changes, abnormal walking gait and fits. Toxic effects of iodine include low blood pressure and slow heart rate, kidney failure, inflammation of small blood vessels (leukocytoclastic vasculitis), overactive thyroid and abnormal liver function.

How is the diagnosis made?

A diagnosis of halogenoderma is usually made on the basis of:

history of halogen exposure
clinical features
histopathology of a skin biopsy. Skin biopsy shows neutrophil white cells with eosinophils and lymphocytes in the epidermis forming small abscesses. There may also be some inflammation in the dermis and involving blood vessels. Bromoderma also tends to show thickening of the epidermis (pseudoepitheliomatous hyperplasia).
blood tests, which may confirm the high halogen level.

However none of these tests are diagnostic and it is the combination that makes the diagnosis.
Treatment

Stopping the halogen will generally result in resolution over 4-6 weeks. Bromide has a long half-life in the body, about 12 days, so it takes some time for the blood level to fall. The clinical improvement parallels the falling blood level of halogen.

Wound care may be required for ulcers.

Sometimes active treatment may also be required, including fluid tablets (e.g. frusemide or ethacrynic acid) or intravenous fluids to increase excretion of the halogen by the kidneys, and/or anti-inflammatory medications, such as topical or oral corticosteroids or oral ciclosporin.

Mild postinflammatory pigmentation or scarring may persist after the skin lesions have healed. Very rarely, halogenoderma may be fatal.

Proposed mechanisms

Several theories have been put forward to explain the development of halogenoderma.

Delayed hypersensitivity reaction/allergic reaction. Iodine binds to protein in the bloodstream and it is believed that an allergic reaction develops against this complex. Lymphocyte transformation tests with iodinated human serum albumin have been positive in some cases.
Excretion of halogen via sweat or oil glands may result in an inflammatory reaction in the skin.
Halogens may make usually non-pathogenic or harmless skin microorganisms pathogenic.

See also: http://emedicine.medscape.com/article/1090031-overview

This: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754371/

Potassium iodide, as a saturated solution, is a valuable drug in the dermatologist's therapeutic arsenal and is useful for the treatment of different diseases due to its immunomodulatory features. However, its prescription has become increasingly less frequent in dermatology practice. Little knowledge about its exact mechanism of action, lack of interest from the pharmaceutical industry, the advent of new drugs, and the toxicity caused by the use of high doses of the drug are some possible explanations for that. Consequently, there are few scientific studies on the pharmacological aspects, dosage and efficacy of this drug. Also, there is no conventional standard on how to manipulate and prescribe the saturated solution of potassium iodide, which leads to unawareness of the exact amount of the salt being delivered in grams to patients. Considering that dosage is directly related to toxicity and the immunomodulatory features of this drug, it is essential to define the amount to be prescribed and to reduce it to a minimum effective dose in order to minimize the risks of intolerance and thus improve treatment adherence. This review is relevant due to the fact that the saturated solution of potassium iodide is often the only therapeutic choice available for the treatment of some infectious, inflammatory and immune-mediated dermatoses, no matter whether the reason is specific indication, failure of a previous therapy or cost-effectiveness.


This: http://www.ncbi.nlm.nih.gov/pubmed/7458376

Twenty-nine patients with erythema nodosum, nodular vasculitis, or erythema nodosum-like lesions associated with Behçet's syndrome were treated with potassium iodide. Administration of the drug for systemic effect showed a substantial effect in 11 of 15 patients with erythema nodosum, seven of ten with nodular vasculitis, and one of four with leg lesions of Behçet's syndrome. Relief of subjective symptoms, including tenderness, joint pain, and fever, occurred within 24 hours. Substantial improvement in the eruption occurred within a few days, and the lesions disappeared completely ten to 14 days after therapy was initiated. The patients to whom the medication was administered shortly after the initial onset of erythema nodosum seemed to respond most satisfactorily. The effect of the drug was marked in the patients with positive C-reactive protein reactions, joint pains, and/or fever. Possible mechanisms by which potassium iodide exerts its effect are discussed.

Here's a page about EN: http://www.medicinenet.com/erythema_nodosum/article.htm

And people telling their stories: http://www.medicinenet.com/erythema_nodosum/patient-comments-287-page2.htm

It's pretty horrible and it seems like what was said in one of the articles cited above might be the cause:
"Halogens may make usually non-pathogenic or harmless skin microorganisms pathogenic."

And not just in the skin, but throughout the body. When the iodine starts kicking that stuff out, apparently one can get quite sick in a number of ways. My guess is that it is not the iodine or potassium iodide making the person sick, but the displaced/detoxing of the bromides/fluorides. But that can be very problematical!

Perhaps the peeps who get some of these reactions should switch over to potassium iodide and back off the lugol's? They mention several times the "immunomodulatory features" of potassium iodide. Maybe it's the combination of potassium and iodine in the potassium iodide formulation that is key?
 
Merci à tous pour vos expériences, liens et précisions si passionnants...
10ème jour, une bonne nuit d'un bon sommeil réparateur (ce n'était pas le cas depuis longtemps)...
Ce matin, au lever 6h, eau chaude salée Celtic, puis juste avant petit déjeuner 7h10 : Vit. C, magnésium, B complexe puis déjeuner : thé sucré Glycine, Kiwi, vers 11H Lugol 12% 5 gouttes...
Comme je n'ai pas d'autres symptômes désagréable je vais me commander Selenium (lien donné par Laura précédemment) :
http://www.amazon.fr/gp/product/B00LHZU2Z0?psc=1&redirect=true&ref_=oh_aui_detailpage_o01_s00
Devrais-je compléter par :
le sélénium 200ug vitamines A, C, E + Zinc - 360 comprimés - Formule antioxydante
http://www.amazon.fr/Hellenia-s%C3%A9l%C3%A9nium-200ug-vitamines-Zinc/dp/B004TAG4IE/ref=sr_1_4?s=hpc&ie=UTF8&qid=1449306483&sr=1-4&keywords=selenium

Thank you all for your experience, links and information so exciting ...
10th day, a good night good sleep (it was not so long ago) ...
This morning at sunrise 6am Celtic warm salt water and then just before 7:10 am Breakfast: Vit. C, magnesium, B complex and breakfast: Glycine sweet tea, Kiwi, 11H to 12% 5 drops Lugol ...
Since I have no other uncomfortable symptoms I will order me Selenium (link given by Laura earlier):
http://www.amazon.fr/gp/product/B00LHZU2Z0?psc=1 redirect = true ref_ = oh_aui_detailpage_o01_s00
Should I be completed by:
Selenium 200ug vitamins A, C, E, Zinc - 360 tablets - Antioxidant Formula
ie = UTF8 http://www.amazon.fr/Hellenia-sélénium-200ug-vitamines-Zinc/dp/B004TAG4IE/ref=sr_1_4?s=hpc qid = 1449306483 sr = 1-4 selenium keywords =
 
Someone posted the following article in a comment on SOTT. Probably too "geeky" and more off-topic. Still, it is interesting to see how important iodine is for life on earth and maybe a clue as to why some microorganisms thrive on lower iodide doses:

Evolutionary roots of iodine and thyroid hormones in cell–cell signaling

_http://icb.oxfordjournals.org/content/49/2/155.full

In vertebrates, thyroid hormones (THs, thyroxine, and triiodothyronine) are critical cell signaling molecules. THs regulate and coordinate physiology within and between cells, tissues, and whole organisms, in addition to controlling embryonic growth and development, via dose-dependent regulatory effects on essential genes. While invertebrates and plants do not have thyroid glands, many utilize THs for development, while others store iodine as TH derivatives or TH precursor molecules (iodotyrosines)—or produce similar hormones that act in analogous ways. Such common developmental roles for iodotyrosines across kingdoms suggest that a common endocrine signaling mechanism may account for coordinated evolutionary change in all multi-cellular organisms. Here, I expand my earlier hypothesis for the role of THs in vertebrate evolution by proposing a critical evolutionary role for iodine, the essential ingredient in all iodotyrosines and THs. Iodine is known to be crucial for life in many unicellular organisms (including evolutionarily ancient cyanobacteria), in part, because it acts as a powerful antioxidant. I propose that during the last 3–4 billion years, the ease with which various iodine species become volatile, react with simple organic compounds, and catalyze biochemical reactions explains why iodine became an essential constituent of life and the Earth's atmosphere—and a potential marker for the origins of life. From an initial role as membrane antioxidant and biochemical catalyst, spontaneous coupling of iodine with tyrosine appears to have created a versatile, highly reactive and mobile molecule, which over time became integrated into the machinery of energy production, gene function, and DNA replication in mitochondria. Iodotyrosines later coupled together to form THs, the ubiquitous cell-signaling molecules used by all vertebrates. Thus, due to their evolutionary history, THs, and their derivative and precursors molecules not only became essential for communicating within and between cells, tissues and organs, and for coordinating development and whole-body physiology in vertebrates, but they can also be shared between organisms from different kingdoms.

Introduction

In vertebrates, thyroid hormones (THs, a collective term for thyroxine, T4, and/or triiodothyronine, T3) are critical molecules for cell–cell signaling. THs regulate and coordinate physiology within and between cells and tissues on an organismal level, in addition to controlling embryonic growth and development via dose-dependent regulatory effects on essential genes [e.g., Gancedo et al. 1997; Hulbert 2000; Clément et al. 2002; Jones et al. 2005; Liu and Brent 2005; Psarra et al. 2006; Walpita et al. 2007; Ebbesson et al. 2008; additional references in Crockford (2002, 2008), and specific effects and actions of TH are described in more detail in Crockford (2004, 2006)]. A number of dose-dependent non-genomic TH actions (including metabolic, ionic, and neurotransmitter-like effects) that occur within minutes have also been documented (e.g. Peter et al. 2000; Wrutniak et al. 2001; Davis and Davis 2002; Hiroi et al. 2006; Sarkar et al. 2006; Lei et al. 2007). Last, it has now been demonstrated that at least in rats, nerves connecting the thyroid gland and suprachiasmatic nucleus of the hypothalamus stimulate rapid release of TH (Kalsbeek et al. 2000, 2006; Kleiverik et al. 2005), which, when needed, allows the brain to bypass classic pituitary-hormone-cascade control over TH production (e.g. Hadley 2000).

Thus, through direct and permissive effects on basic biochemical cell functions, regulatory genes, and other hormones, THs are known to influence virtually all biological systems from the point of conception onward, including differentiation of embryonic and adult brain stem cells; regulation of early embryonic cell migration, differentiation, and maturation; regulation of embryonic and postnatal somatic growth; regulation of embryonic and postnatal development of the brain and eyes; generation of energy in mitochondria through regulation of ATPase; regulation of mitochondrial DNA replication; regulation of cellular sodium/potassium and calcium ion pumps; regulation of brain function and neurogenesis; regulation of hair growth; regulation of production of adrenal hormones necessary for stress response; regulation of pigment production in the hair and skin; regulation of development and function of the gonads; regulation of metabolism and adaptation to daily and seasonal changes; regulation of metamorphosis in amphibians and certain families of fish; regulation of osmoregulatory changes in anadromous and catadromous fish; regulation of adaptive coloration; and regulation of mammalian hibernation.

While invertebrates do not have thyroid glands, many use ingested THs for initiating and/or sustaining critical developmental stages, while many organisms (including plants, insects, zooplankton, and algae) are known to store iodine as TH precursor molecules: mono-iodotyrosine (MIT), di-iodotyrosine (DIT), iodocarbons, or iodoproteins (Eales 1997; Johnson 1997; Heyland and Moroz 2005). While insects do not appear to use MIT or DIT for TH-like developmental regulation, they do produce similar hormones that act in TH-like fashion (Nijhout 1999; Wheeler and Nijhout 2003; Flatt et al. 2006), as do many plants (Eales 1997; Farnsworth 2004). Gut-inhabiting bacteria use host THs as a source of iodine (DiStefano et al. 1993). Such common roles for THs, iodotyrosines, and analogous molecules across kingdoms suggest that a common endocrine signaling mechanism may account for coordinated evolutionary change in all multi-cellular organisms, as I have previously proposed (Crockford 2004, 2006, 2008), via time-dependent and dose-dependent effects on the fates of cells, proliferation of cell lineages, and development of critical brain architecture.

Here, I expand my premise that THs or their precursor molecules are critical drivers of evolution in multicellular organisms by suggesting that this mechanism began with an essential role for iodine in the first early cells. Iodine is the key constituent of THs and iodotyrosines and is crucial to life for virtually all extant organisms, including evolutionarily-ancient cyanobacteria. In part, iodine is critical, because its antioxidant properties protect cell proteins, nucleotides, and fatty acids from the chemically disruptive effects of oxygen (e.g. Salacinski et al. 1981; Venturi and Venturi 1999; Hulbert 2000; Miller 2006; Küpper et al. 2008). Although essential in vertebrates, more generally iodine is considered to be a non-essential trace element/micronutrient (Kobayashi and Ponnamperuma 1985), a characterization that belies what is now known about its utilization in unicellular organisms and the critical role it plays in the Earth's atmosphere (Fuge and Johnson 1986; Councell et al. 1997; Eales 1997; Gilmour et al. 1999; Wong et al. 2002; Amachi et al. 2003, 2005a, 2005b; Baker 2005).

I propose that during the evolution of early cells, the ease with which environmental iodine reacts with water and simple biological compounds—its active redox chemistry—explains why this relatively rare inorganic element, over evolutionary time, became a cornerstone of cell–cell signaling and a critical component of our atmosphere. While some details regarding iodine cycling from rock and soil, to water and biota, and then to the atmosphere and back remain obscure, it is clear that iodine in one form or another is more essential to all life forms than has been appreciated previously. In fact, it is entirely possible that iodine may be the key to explaining the origin of life on Earth, as suggested by Gilmour et al. (1999).

Although precise details of the biochemical machinery involving iodine and THs are not yet fully understood, what I will try to do here is incorporate what I have been able to tease from the literature into a coherent and plausible scenario to answer the question alluded to more than 10 years ago by Johnson (1997): what are the evolutionary roots of iodine dependency?

Unique properties of iodine

The molecular mass of iodine (126.90 U) is the highest by far of all elements used in biological systems. This unique character is also reflected in its atomic number: the proton count per atom for iodine (I 53) is significantly higher than any other common or essential trace element used by living organisms, including zinc (Zn 30) and iron (Fe 26). The high mass and proton count relative to other elements provides a partial explanation for the fact that iodine is biochemically unique. Iodine atoms, like other halogens (fluorine, chlorine, bromine, and astatine), are highly reactive, because they lack a full outer shell of electrons. All halogens thus have a strong tendency to gain an electron and regularly occur as diatomic molecules (e.g. I2). While chlorine and bromine are relatively more abundant in modern marine waters, iodine is the more biological reactive (e.g. Küpper et al. 2008; Truesdale 2008).

Iodine exists in several common inorganic oxidation states, including iodide (I–), molecular iodine (I2), and iodate (IO3−), providing the potential for active redox chemistry. Iodate is the most thermodynamically stable form. I2 is a powerful catalyst (Grätzel 2001; More et al. 2005; Ahmed and van Lier 2006; Wu et al. 2006) and like many metals capable of catalyzing biochemical reactions, it functions as a Lewis acid (Žmitek et al. 2006; Hazra et al. 2008). When incorporated into complex molecules, such as glycoproteins, iodine appears to confer some of its reactivity on the entire molecule. Iodotyrosines, for example, are known to be good catalysts (Harshman 1979).

Iodine is considered a trace element geochemically. It is rare in igneous rock but relatively more common in sedimentary rock such as sandstone and limestone (Fuge and Johnson 1986). Iodine is both water-soluble and volatile in several of its inorganic forms: it dissolves out of rock during weathering and cycles with water and water vapor throughout the lithosphre, cryosphere, and atmosphere (Jones and Truesdale 1984; Fuge and Johnson 1986; Truesdale and Jones 1996; Gilmour et al. 1999; Baker et al. 2000; Baker 2005), as depicted in Fig. 1.

Environmental iodine and the origin of life

The six chemical building blocks of early life are usually considered to be hydrogen (H), carbon (C), oxygen (O), nitrogen (N), phosphorus (P), and sulphur (S), which combine in various ways to make up the essential sugars, fatty acids, amino acids, and nucleotides that form the basic constituents of metabolism (Smith and Morowitz 2004; Falkowski et al. 2008; Melkikh and Selezneu 2008). Many of these elements are also important to the Earth's atmosphere (e.g. Commoner 1965; Kasting and Siefert 2002). Researchers have attempted to explain how and why these basic elements came together in the earliest life forms (e.g. Bada 2003; Griffiths 2008; Jalasvuori and Bamford 2008), and while there is disagreement over whether the ability to replicate (via RNA) or generate energy (via metabolism) came first, or whether both arose at the same time (before or after the advent of cell walls), such disputes are immaterial to this discussion.

The first early cells (LUCA, Last Universal Common Ancestor) almost certainly had a simple metabolism compared to modern forms, with less than a full complement of essential amino acids and perhaps a few non-specific enzymes (remembering that enzymes are simply biochemical catalysts that are molecularly larger and more specific than inorganic catalysts). Aromatic amino acids (phenylalanine, tyrosine, and tryptophan) appear to have arisen some time after LUCA arose, as did more complex and specific enzymes (Ahmad and Jensen 1988). While the actual incorporation of iodine into essential biochemistry appears to have come after the rise of LUCA (Barrington 1962), I suggest its influence probably started with LUCA itself. To understand why this may be so, I review below the role of iodine in modern organisms and the atmosphere.

How modern organisms use iodine

Although it is not always clear exactly what iodine is used for biochemically, plants are known to take up iodine from water and store it, often as MIT, DIT, or THs (Jones and Truesdale 1984; Eales 1997). Iodine is also coupled to various carbohydrates, polyphenols, and proteins (Küpper et al. 2008; Truesdale 2008). Decaying vegetation absorbs and fixes even more iodine (about 10 times more), so that soils rich in organic matter, such as peat, are known to be particularly rich in stored iodine (Fuge and Johnson 1986). The question arises: how and why does iodine enter cells?

Many unicellular marine phytotplanktonic species (e.g., cyanobacteria, dinoflagellates, green algae, and diatoms), and photosynthetic marine and aerobic soil bacteria, are known to reduce inorganic iodate to iodide at or within their cell walls (Wong et al. 2002; Amachi et al. 2003, 2005a; Chance et al. 2007; Truesdale 2008). While some iodine apparently gets transferred into the cytoplasm during this process, much appears to be released as iodide and various organic iodinated compounds, including methyl iodide, CH3I (Baker et al. 2000; Wong et al. 2002; Baker 2005). Macroalgae (kelp) also release iodide and while they are known for their ability to accumulate large quantities of iodine (primarily as iodotyrosines), the function of these stored reserves in kelp has not been determined (Küpper et al. 1998, 2008).

For some single-celled organisms, including most anaerobic bacteria, fungi, viruses, and yeasts, I2 is toxic to the cell membrane (McDonnell and Russell 1999). However, at least some choanoflagellates and most α-proteobacteria (Amachi et al. 2005b) are resistant to I2, as are all animals. Just because some organisms are killed by I2 does not necessarily mean they do not use iodine, only that they must get their iodine in another form. For example, the Escherischia coli bacteria that inhabit rat intestines (for which I2 is lethal) are known to bind significant amounts of host THs to their outer cell membranes and to excrete iodine in the form of iodide (DiStefano et al. 1993), suggesting that some THs are converted to DIT or MIT within the cell membrane and utilized or broken to generate other iodine species within the cell.

Certain ferric iron and sulphate-reducing anaerobic bacteria can also reduce iodate to iodide (Councell et al. 1997; Truesdale 2008), as can some facultative anaerobes (Farrenkopf et al. 1997), suggesting that the earliest anaerobic cells might have had this ability also. The fact that virtually all species are able to convert iodate to iodide and that iodide is known to enter cells in many of these suggests that iodine has always entered cell cytoplasm and participated in essential biochemistry. {A clue as to why lower doses of iodide feed microorganisms instead of killing them?} While more research is clearly needed to unravel the precise roles that iodine and iodinated molecules play in cellular metabolism, if iodine has always been essential to cells then iodotyrosines may have a longer evolutionary history than previously thought. Iodotyrosines are known to form spontaneously (Nishinaga 1968; Cahnmann and Funakoshi 1970), although more slowly and with a lower yield than when catalyzed by enzymes, as occurs in vertebrate thyroid glands (Hulbert 2000). Iodotyrosines are highly reactive with other molecules (Harshman 1979), suggesting they may have been one of the first and most crucial molecules effecting cell–cell signaling in multicellular organisms.

Iodine in the atmosphere

The ability of microbes to convert thermodynamically stable inorganic iodate to highly reactive iodide (with some retained, most released into the environment) explains why most iodine in deep marine waters takes the form of iodate, whereas marine surface waters (where most microorganisms reside) have relatively more iodide (Amachi 2005b; Truesdale 2008; Küpper et al. 2008). Iodide atoms at the sea surface enter the atmosphere as volatized I2 and iodocarbons, which react readily with atmospheric oxygen. Volatized I2 and iodine compounds not only break down ozone (Wang et al. 2006; Read et al. 2008) but provide nuclei for the particulate matter of clouds, the seeds of rain (Baker et al. 2000; Baker 2005). The incorporation of iodine into rain recycles it back to land, where it becomes available for uptake by terrestrial plants and soil bacteria (Jones and Truesdale 1984; Fuge and Johnson 1986; Truesdale and Jones 1996; Amachi et al. 2003), as summarized in Fig. 1.

The intimate relationship between iodine used by unicellular marine organisms and atmospheric cycling almost certainly has a long evolutionary history. I suggest that iodine must have played a crucial role in the development and evolution of our atmosphere primarily due to its reactive relationship with oxygen. Three to 4 billion years ago (Ga), the Earth's atmosphere was very low in oxygen (Falkowski et al. 2008). Most evidence points to a dramatic increase in atmospheric oxygen just about the time that the abundance of photosynthetic cyanobacteria rose dramatically, ∼2.3–2.7 Ga (Commoner 1965; Kasting and Siefert 2002; Canfield 2005). Since the by-product of photosynthesis is oxygen, it is presumed that the sudden increase in atmospheric oxygen was due to biological activity. Since modern cyanobacteria and photosynthetic marine bacteria release significant amounts of iodine that subsequently enter the atmosphere, it is reasonable to suggest that in evolutionary terms, iodine became an important constituent of the atmosphere at the same time as oxygen. This simultaneous rise of atmospheric oxygen and iodine appears to have been a turning point for the history of life on Earth, because only after iodine and oxygen became major constituents of the atmosphere did eukaryotes and multicellular organisms arise. I suggest that oxygen alone would not have done the trick.

Iodine, tyrosine, and the evolution of photosynthesis

Iodine and oxygen became critical to multicellular life and the evolution of vertebrates (e.g. Falkowski et al. 2005) only after the amino acid tyrosine came into the picture. As stated previously, tyrosine and other aromatic amino acids apparently arose some time after LUCA. Phosphorylated tyrosines, which are critical cell-signaling molecules for all living metazoans and their closest protist relatives (e.g. choanoflagellates), require the actions of a tyrosine kinase for their synthesis. The genes for these enzymes are known to be evolutionarily ancient (King 2004; Manning et al. 2008). Tyrosine in vertebrates is an essential precursor to melanin, catecholamines (including neurohormones such as dopamine, epinephrine, and norepinephrine) and of course, THs and all iodotyrosines. Tyrosine is also required for the PSII component of water-based oxygen photosynthesis (Gupta 2003; Nugent et al. 2004). Tyrosine has been described as uniquely reactive (Harshman 1979), especially with iodine.

Tyrosine has thus been available and critical to cellular function for a very long time, although it was not present initially. So when and how did tyrosine enter the picture? In all living organisms, tyrosine is synthesized from other compounds via an enzyme-mediated process (e.g. Smith and Morowitz 2004) that LUCA did not possess (Ahmad and Jensen 1988; Griffiths 2008). I suggest, therefore, that early in its evolutionary history, tyrosine was initially generated by the catalytic actions of iodine in the cytoplasm of LUCA, as outlined below.

Oxidation reactions with iodate at surface of LUCA cells would have produced iodide, some of which probably entered the cytoplasm (as I2) through permeable cell walls (Deamer 2008; Melkikh and Seleznev 2008). I2 in the cytoplasm, acting as a catalyst, would have made new kinds of compounds available to the cell. One of those compounds may have been the amino-acid tyrosine.

I suggest that some descendants of LUCA might have had the ability to generate tyrosine from an available sugar, with I2 acting in its capacity as a metal-like catalyst, before the specialized enzymes now necessary for biosynthesis of this molecule had evolved (Ahmad and Jensen 1988; Griffiths 2008). Catalysis of this sort has previously been proposed (utilizing a little-known metal, montmorillonite) to explain the origins of RNA (Ferris 2006). Once tyrosine was present, the metabolic steps to photosynthesis could evolve and once tyrosine as a component of photosynthesis had become necessary for survival, non-specific enzymes could evolve into specialized ones capable of synthesizing tyrosine faster and more efficiently. This kind of selective process has been used to explain the evolution of other specialized essential enzymes (Gehring 2005; Badger et al. 2006).

As tyrosine is especially reactive with iodine, some iodotyrosines probably formed spontaneously in these primitive cells. Iodotyrosines and iodoproteins are rather reactive themselves because of their iodine component; they bind to other molecules to make more complex compounds and can insert themselves into lipid membranes (Harshman 1979). Iodotyrosines also catalyze other reactions and scavenge free radicals (Oziol et al. 2001).

Such reactivity would have made iodotyrosines useful biochemically well before they were used as cell–cell signaling molecules in multicellular organisms.

Origin of multicellularity and a new role for THs

The first multicellular organisms appear to have needed two critical innovations: a way for cells to come together and a way for them to communicate. It has been suggested, for example, that multicellularity might have arisen as a consequence of incomplete cell division, a development that would have created connections between cells, such as seen in some colonies of modern volvocine algae. Multicellular organisms might also have arisen subsequent to the production of extracellular matrices that bind cells together (Sachs 2008), as such matrices create unique opportunities for cell–cell communication (Brodsky 2006). The essential biochemical machinery for effective cell–cell communication, it turns out, is found in mitochondria.

It is now widely accepted that photosynthetic α-proteobacteria became the mitochondria of eukaryotic cells (Meyerowitz 2002; Gabaldón and Huynen 2003; Gupta 2005). Some modern cyanobacteria that have both chloroplasts and mitochondria are known to form self-colonies as well as symbiotic colonies with fungi and yeast (Badger et al. 2006), a life style similar perhaps to the first multicellular organisms. Since it is clear that such organisms probably possessed iodotyrosines (the precursors of THs), it should come as no surprise that the primary sites of action for THs, at least in vertebrates, are in mitochondria.

Mitochondria are the “power plants” of eukaryotic cells; they generate energy via oxidative phosphorylation of ATP, which forces cations (H+ or Na+) across cell membranes. In vertebrates, THs up-regulate the production of the ATPase enzyme that drives this potassium-sodium pump (Hadley 2000; Hulbert 2000). ATPases are found in all life forms (Axelsen and Palmgren 1998), including living Archaea, which suggests that the cellular machinery required for ATP production is ancient (Müller and Grüber 2003) and that enzymes specific for ATP production arose very early in the evolution of life itself.

Therefore, although this remains to be demonstrated, I suggest it is possible that iodinated tyrosines, as evolutionary and biochemical precursors of THs, may up-regulate the production of ATPase in non-vertebrate mitochondria. Plants and invertebrate cells also have potassium-sodium pumps driven by ATPase, which suggests that stored MIT, DIT, and/or THs may play a role in the regulation of ATPase (Glynn 1993; Gimmler 2000). In vertebrates, THs also up-regulate mtDNA replication (Wrutniak et al. 2001), enabling cells to increase the absolute number of mitochondria available to generate energy when needed (Hulbert 2000). THs also up-regulate the expression of many mitochondrial genes in muscle cells at work (Clément et al. 2002).

As THs perform such significant communication within vertebrate cells, it seems eminently plausible that iodinated tyrosines, or other TH derivatives, play similar roles in non-vertebrates and also that such signaling roles are evolutionarily ancient. Highly reactive iodinated tyrosines, because they form spontaneously and move readily through permeable membranes, would have made exceptionally good cell–cell signaling molecules.

TH and the origins of coordinated development

In vertebrates, THs of maternal origin, either deposited in egg yolk or supplied via the placenta (Crockford 2006, 2008) regulate embryonic development of the adult thyroid gland. In vertebrates with metamorphic stages, THs from egg yolk regulate initiation of embryonic development of the thyroid gland, which, on further growth, produces the THs needed for subsequent transformation to the adult form (Inui and Miwa 1985; Kluge et al. 2005).

Jawless cyclostomes (lampreys, hagfish), the most primitive living vertebrates, have a thyroid gland as adults but retain an endostyle (the evolutionary precursor of the thyroid gland) during their larval stage. Lamprey larvae (ammocoete) are freshwater forms and the larval endostyle produces the THs necessary for metamorphic transformation to the adult marine form (Barrinton 1962; Kluge et al. 2005). Protochordates, such as amphioxus (Branchiostoma sp.) and ascidians (sea-squirts), also possess an endostyle (Barrington and Thorpe 1965; Frederikkson et al. 1984) that synthesizes both iodotyrosines and THs. While the endostyle of adult amphioxus has been shown to integrate iodinated compounds into a specialized mucoprotein used in feeding, it has recently been demonstrated that metamorphosis is regulated by triiodothyroacetic acid, a TH derivative produced by the endostyle of the larva (Paris et al. 2008). Note that in lampreys, TH production in the primitive thyroid gland begins in larvae just before the yolk sac is used up (Kluge et al. 2005), which appears to be a general vertebrate pattern.

Thus, endogenously produced THs initiate metamorphosis in vertebrates, while non-vertebrates, such as echinoderms, that are known to use THs as developmental signaling molecules, use exogenous THs extracted from ingested algae to initiate metamorphic transformation (Heyland and Moroz 2005; Flatt et al. 2006; Heyland et al. 2006). I contend, therefore, that iodinated tyrosines necessary for the regulation of larval development must be present in the maternally produced egg sacs of protochordates and primitive vertebrates, suggesting that the ability to use TH derivates for regulation of larval development must already have existed before even the most primitive vertebrates arose.

TH, metamorphosis, and osmoregulation: the origin of lungs

THs regulate metamorphosis in a number of vertebrate taxa in which the transformation involves not only morphological change but osmoregulatory ones necessitated by a profound shift in habitat. Thus, lampreys transform from freshwater larvae into marine adults, and amphibians (frogs, toads, and salamanders) change from freshwater to terrestrial forms.

In several groups of teleost fish, THs are critical for osmoregulation during life-history shifts from marine to freshwater or freshwater to marine, transitions that are accompanied by moderate to profound metamorphic transformations. For example, flatfishes transform from pelagic larvae living in brackish estuaries to benthic saltwater forms (with a dramatic change in morphology), three-spined sticklebacks change from heavily armored marine forms to less-armored freshwater forms, and juvenile salmon change from spotted freshwater parr to unspotted marine smolts (Barrinton 1962; Inui and Miwa 1985; Peter et al. 2000; Schreiber 2001; Klaren et al. 2007).

Clearly, endogenously produced THs are required for metamorphosis in all chordates, a process that often involves an osmoregulatory transformation as well as a morphological one. In this context, the fact that the thyroid gland derives from foregut tissues is relevant to the observation that the gut is a key osmoregulatory organ in vertebrates (Specker 1988). Thus, the salt-balancing and ion-balancing role of THs in relation to shifts in life-history or evolutionary changes in marine versus freshwater habitats may be more important than previously thought because of the role that THs also play in embryonic development.

The critical role that THs are known to play in osmoregulation suggests that iodinated tyrosines and THs stored in endostylar cells may have been essential to the evolutionary transformations from saltwater to freshwater and from water to land, similar to the developmental metamorphosis associated with changes in habitat by some vertebrates, as discussed in the previous section. Since THs and their precursors have a long evolutionary history of regulating early development, I suggest that the up-regulation of TH production in gut tissue, a necessary response for adaptation to freshwater by a marine organism, may have initiated enough of a developmental shift to generate an involution of gut tissue in the embryos of the first freshwater colonizers, a pouch that went on to became the primitive thyroid gland. Another involution in the same tissue (the lung) may have been created as an inevitable consequence of this developmental shift in response to adaptation to freshwater, or it may have come later, with the shift to land.

Support for this hypothesis is provided, in part, by studies on the function of specific genes that are critical for vertebrate development. For example, thyroid transcription factor (TTF-1 or nkx2.1) is a homeobox gene required for embryonic development of the forebrain, lung, and thyroid gland. This gene has a homologue in the amphioxus embryo that regulates development of the cerebral vesicle and the endostyle (Rohr and Concha 2000; Kluge et al. 2005). As THs are known to be required for the early embryonic expression of the fibroblast growth factors and bone morphogenic proteins required for differentiation of the thyroid gland and lung tissue from foregut mesoderm (e.g. Sekine et al. 1999; Ishizuya-Oka et al. 2001; Cardoso and Lü 2006), it is quite likely that nkx2.1 is also regulated by THs.

The placement of iodine-storing, TH-manufacturing gut cells inside the organism, concentrated within a discrete organ (the endostyle) may have provided a distinct advantage to these primitive vertebrates, because it permitted more efficient osmoregulation in fresh water, ensuring the perpetuation of this change. Subsequent selection and modification of the endostyle into a thyroid gland would have further refined this design.

A move from saltwater to land could have precipitated a similar, but not identical, shift in gut development as a consequence of the osmoregulatory response of TH-generating tissues to a complete lack of salt (which, in terms of salt balance, would be physiologically similar to a change from saltwater to freshwater). This transformation involved two involutions of embryonic gut tissue, one that became the thyroid gland and the other, the lung. Eventually, due to a slight offset in the control of timing during development of the gut, features of lung development could be selected somewhat independently from features of the thyroid gland (although they remain closely linked). It is nevertheless significant that while both the thyroid gland and the lung derive from the same tissue, the thyroid gland begins to form first (in humans, about 1 day before lungs begin).

Summary and conclusions

Due to the unique chemical properties of iodine, it probably became critical to life on Earth as soon as LUCA arose, between 3 and 4 Ga (Fig. 2). Early cells that used the conversion of idodate to iodide as a protective measure against oxidative damage to their cell membranes would have survived the longest. In these cells, some iodide almost certainly migrated into the cytoplasm as a consequence of oxidation reactions at the membrane interface with the environment (a hypothesis that is testable experimentally using primitive cell types under a variety of conditions that, to the best of our knowledge, could have existed 3–4 Ga). Since iodide naturally combines to form I2, which is a powerful catalyst, the presence of I2 within cytoplasm might initially have catalyzed the reactions necessary for the generation of energy and for salt/ion balance, and later, the non-enzymatic synthesis of tyrosine molecules from simple available sugars (such hypotheses are also testable experimentally). Once tyrosine was available for inclusion in cellular metabolism, the biochemical machinery for photosynthesis could evolve.

Once unicellular photosynthetic organisms were prospering, tyrosine was a well-established amino acid. Iodinated tyrosines probably became important about this time, in part, because they were good catalysts, reacted readily with others to form new complex molecules, and moved easily through permeable membranes. It is probable that iodinated tyrosines became regulators of ATPase production in early mitochondria and if so, their role as gene regulators may predate the first eukaryotes (this hypothesis can be tested experimentally by investigating whether iodinated tyrosines or their derivatives are able to up-regulate the production of ATPase in non-vertebrate mitochondria). Due to the fact that iodinated tyrosines could move easily between cells, they were likely utilized as cell–cell signaling molecules in multicellular organisms, especially for the coordinated operation of mitochondrial metabolism (including regulation of essential genes) as well as for replication of mtDNA. Eventually, MIT, DIT, and THs became ubiquitous signaling molecules used in communicating within and between cells, tissues, and organs, and for coordinating whole-body physiology and embryonic development; they could even be shared between organisms from different kingdoms.

Therefore, for very early life forms, iodine would have served as a critical antioxidant and catalyst for the synthesis of new biomolecules and thus, may have been essential for the development of life itself. Either by itself, or coupled to tyrosine, iodine became key to the maintenance of salt balance and the generation of energy in early cells. Therefore, it appears that iodinated tyrosines and their derivatives, which are so important to vertebrate development and physiology, have a very ancient history. Clearly, the coupling of iodine with tyrosine was a critical step in the evolution of complex cell–cell signaling and thus crucial to evolution itself.

These profound effects were not limited to living organisms, however; because of the way that biochemical processes mobilize and transform inorganic forms of iodine into organic forms that cycle with water and water vapor throughout the lithosphere, cryosphere, and atmosphere, the utilization of iodine by early cells actually transformed the Earth's environment. The innovation of photosynthetic metabolism billions of years ago changed, forever, the composition of the Earth's atmosphere by dramatically increasing levels of oxygen and iodine. This atmospheric enrichment with oxygen and iodine set the stage for the rise of metazoans and subsequent evolution of vertebrates. If not for the conversion of thermodynamically stable iodate to iodide at the surface of the ocean by marine organisms, volatile forms of iodine would not have been available for addition to the atmosphere; if not for the active conversion of iodine species by marine organisms and the subsequent participation of these molecules in cloud formation, dissolved iodine would not have cycled back to continents. Without this atmospheric cycling of iodine from the ocean to terrestrial habitats, there would not have been enough bioavailable iodine present to support life on land, even with abundant oxygen in the atmosphere.

A significant role for iodine in biological and atmospheric evolution has not previously been suggested, which is why many of the statements made here must be tentative. Clearly, more research is needed on the basic chemical nature of iodine. However, it is apparent even now that iodine cycling is a significant and perhaps unique phenomenon that links inorganic chemistry to biology and geological processes to organic evolution. Life as we know it probably would not have evolved without iodine.
 
Laura said:
Perhaps the peeps who get some of these reactions should switch over to potassium iodide and back off the lugol's? They mention several times the "immunomodulatory features" of potassium iodide. Maybe it's the combination of potassium and iodine in the potassium iodide formulation that is key?

If there are strong reactions, this concept is also important:

"Stopping the halogen will generally result in resolution over 4-6 weeks. Bromide has a long half-life in the body, about 12 days, so it takes some time for the blood level to fall. The clinical improvement parallels the falling blood level of halogen."

A person could switch to potassium iodide, but if the reactions don't stop or rather increase, then backing off entirely until the reactions disappear sounds like the reasonable thing to do.

Lugol has advantages over KI, specially in those with breast disease. Breasts prefer iodine and not iodide. So those with reactions AND a specific breast disease might want to back off the dose of lugol to the very minimum AND take the KI.

According to Dr. Brownstein,

I have used various iodide preparations for years, with mixed success. Although they are effective for certain conditions such as sinusitis, there is clearly an advantage to using a combination of iodide and iodine together. The results that I have seen in my patients have convinced me that using a combination of iodide and iodine is much more effective and appropriate treatment than using iodide alone.

I also wonder about the increasing nuclear fallout from multiple sources. It is known that some of that nuclear toxicity increases (not decreases) over time. We might be dealing with some detox reactions not only from halides, but also excess oxidative stress from radioactivity? In that case, high doses of KI might be better in case of reactions, to see if it helps.

Some thoughts.
 
Gaby said:
I also wonder about the increasing nuclear fallout from multiple sources. It is known that some of that nuclear toxicity increases (not decreases) over time.

A brief recap on this concept:

http://www.sott.net/article/226021-Detoxify-or-Die-Natural-Radiation-Protection-Therapies-for-Coping-With-the-
Fallout-of-the-Fukushima-Nuclear-Meltdown

More than 20 years after the [Chernobyl] catastrophe, due to the natural migration of radionuclides, the dangerous consequences in these areas have not decreased, but have actually increased and will continue to do so for many years to come.

The radioactive elements Caesium-137 (Cs-137), Strontium-90 (Sr-90), Plutonium (Pu), and Americium (Am) released in Chernobyl concentrate in the roots of plants and it is now known that they will continue to be mobilized for decades, even up to several hundreds of years into the future. Agricultural products have contained - and will continue to contain - radioactivity in all of the Northern Hemisphere countries contaminated by Chernobyl.

The level of radionuclide incorporation in our bodies varies according to each organ. In Chernobyl the most affected organs (from autopsies) were the thyroid gland, the adrenal glands, the pancreas, the thymus, the skeletal muscle, the spleen, the heart and the liver (in decreasing order).

The thyroid gland is the most affected since radioactive iodine (Iodine-131) binds to it, making supplemental non-radioactive iodine a key therapy in the case of nuclear radiation. The natural iodine will bind to the thyroid, blocking the radioactive iodine from binding to it. The affliction of the adrenals is worthy of attention, since there were many "new" diseases that emerged after the Chernobyl disaster whose symptoms resemble those of adrenal fatigue.

Radiation poisoning damages organ tissues by excessive exposure to ionizing radiation. Ionizing radiation consists of particles or electromagnetic waves that are energetic enough to detach electrons from atoms or molecules, thus ionizing them. Direct ionization from the effects of single particles or single photons produces free radicals, which are atoms or molecules containing unpaired electrons, and which tend to be especially chemically reactive due to their electronic structure.

This means that they become chemically unstable and highly reactive ions as free radicals are formed. These unstable metabolic by-products strive to stabilize by 'stealing' a replacement electron from any neighboring molecule, leaving even more damaged molecules in their wake. This is how free radicals in our bodies are produced and cause inflammation, a process that is best known as oxidative stress, oxidative damage or lipid peroxidation. Oxidation can even cause debilitating changes to your DNA.

Nuclear or ionizing radiation that penetrates the body can affect your body in a number of different ways, and the adverse health effects of extreme radiation exposure may not be apparent for many years.

Among the specific health disorders associated with Chernobyl radiation there was increased morbidity and prevalence of the following groups of diseases:

Circulatory system (owing primarily to radioactive destruction of the endothelium, the internal lining of the blood vessels).
Endocrine system (especially nonmalignant thyroid problems).
Immune system ("Chernobyl AIDS," increased incidence and seriousness of all illnesses).
Respiratory system.
Urogenital tract and reproductive disorders.
Musculoskeletal system (including pathologic changes in the structure and composition of bones: osteopenia and osteoporosis).
Central nervous system (changes in frontal, temporal, and occipitoparietal lobes of the brain, leading to diminished intelligence and behavioral and mental disorders).
Eyes (cataracts, vitreous destruction, refraction anomalies, and conjunctive disorders).
Digestive tract.
Congenital malformations and anomalies (including previously rare multiple defects of limbs and head).
Thyroid cancer (All forecasts concerning this cancer have been erroneous; Chernobyl-related thyroid cancers have rapid onset and aggressive development, striking both children and adults. After surgery the person becomes dependent on replacement hormone medication for life.)
Leukemia (blood cancers) not only in children and liquidators, but in the general adult population of contaminated territories.
Other malignant neoplasms.

Other health consequences of the Chernobyl catastrophe include:

Changes in the body's biological balance, leading to increased numbers of serious illnesses owing to intestinal toxicoses, bacterial infections, and sepsis.
Intensified infectious and parasitic diseases (e.g., viral hepatitis and respiratory viruses). 
Increased incidence of health disorders in children born to radiated parents (both to liquidators and to individuals who left the contaminated territories), especially those radiated in utero. These disorders, involving practically all the body's organs and systems, also include genetic changes.
Catastrophic state of health of liquidators (especially liquidators who worked in 1986 - 1987).
Premature aging in both adults and children.
Increased incidence of multiple somatic and genetic mutations.
 
Some clues as to how much iodine from lugol is needed in case of specific glandular conditions.

The Extrathyronine Actions of Iodine as Antioxidant, Apoptotic, and Differentiation Factor in Various Tissues

_http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752513/

Summary

We review evidence showing that, in addition to being a component of the thyroid hormone, iodine can be an antioxidant as well as an antiproliferative and differentiation agent that helps to maintain the integrity of several organs with the ability to take up iodine. In animal and human studies, molecular iodine (I2) supplementation exerts a suppressive effect on the development and size of both benign and cancerous neoplasias. Investigations by several groups have demonstrated that these effects can be mediated by a variety of mechanisms and pathways, including direct actions, in which the oxidized iodine dissipates the mitochondrial membrane potential, thereby triggering mitochondrion-mediated apoptosis, and indirect effects through iodolipid formation and the activation of peroxisome proliferator–activated receptors type gamma, which, in turn, trigger apoptotic or differentiation pathways.

{This concept is actually explained very comprehensively in Dr. Brownstein's book}

Conclusions

We propose that the International Council for the Control of Iodine Deficient Disorders recommend that iodine intake be increased to at least 3 mg/day of I2 in specific pathologies to obtain the potential extrathyroidal benefits described in the present review.

Introduction

Iodine is a crucial component in the formation of thyroid hormone, and public health policies have been established to supply deficient populations with the necessary amount of this element in order to eradicate the iodine deficiency diseases, that is, endemic goiter and cretinism. The International Council for the Control of Iodine Deficiency Disorders proposed that 150–299 μg/day is adequate to cover the thyroid requirement, and the 10th edition of Recommended Dietary Allowances published in 1989 suggested that the maximal allowable dietary dose of iodine be 1.0 mg/day for children and 2.0 mg/day for adults (1). These limits were established considering that particular individuals with underlying or evident thyroid pathologies (Table 1) can develop hyper- or hypothyroidism if they are exposed to doses higher than 1.5 mg/day (2–4). However, reviews by Baker and Hollowell in 2000 (4), Bürgi in 2010 (5), and Leung and Braverman in 2012 (6) reported that iodine supplements at low (1.5–8 mg/day) and intermediate doses (10–32 mg/day), ingested from a variety of sources (Table 2), are well-tolerated in euthyroid subjects, maintaining levels of thyroid hormones (thyroxine and triiodothyronine) and thyrotropin within normal limits (3–16). Only very high doses (>30 mg/day), mainly as iodide (I−), generate hypothyroidism and goiter, which rapidly revert to normal when these individuals stop taking the high-iodine supplement. On the other hand, considerable evidence indicates that iodine per se can ameliorate physiopathologies of several organs that take up iodine, primarily the thyroid, mammary, and prostate glands and potentially the pancreas, gastric, and nervous systems, and it may act as an antioxidant in the whole organism if this element is ingested at concentrations higher than 3 mg/day (17). Dose-response studies in humans demonstrated that iodine at concentrations of 1.5 mg/day or less had no effect, whereas concentrations of 3, 5, and 6 mg/day, mainly in the form of molecular iodine (I2), exhibited significant beneficial actions in benign pathologies (mastalgia or prostatic hyperplasia) and antineoplastic effects in early and advanced breast cancer (14–16,18,19). These studies included treatments lasting from 5 weeks up to 2 years, and at these concentrations they do not exert any secondary effect. Some of these studies also analyzed higher concentrations of iodine (9 and 12 mg/day) and showed that these doses resulted in the same benefits but caused transient hypothyroidism in 20% of the studied individuals, while also producing an assortment of minor side effects (upper respiratory tract infection [26%], headache [20%], sinusitis [12%], nausea [9.9%], acne [9.0%], back pain [9.0%], diarrhea [9.0%], dyspepsia [8.1%], rash [8.1%], and abdominal pain [6.3%]) which disappeared when the high iodine supplement is stopped (15). Antiproliferative and apoptotic effects have also been observed in preclinical studies, in which rodents (20,21) or tumoral cell lines (3,22) are exposed to micromolar concentrations of I2.

{I reckon those were detox reactions}

Sources and Effects of Excess Iodine

Here we review information related to the antioxidant, apoptotic, and differentiation effects of iodine that do not include the actions of thyroid hormones. Chemically, the elemental form of iodine (I2) with an atomic weight of 125.9015 is the only substance that should be called “iodine”; however, the term “iodine” is widely used to describe many compounds in which the active principle is iodine per se. These include the different oxidation states of iodine (iodinium [I+], iodine free radical [I0], I2, etc.), iodine-containing salts (KI, NaI), and preparations of I2 together with stabilizing components (povidone–iodine, iodine tincture, or Lugol). In the present work, the term “molecular iodine” or I2 corresponds to any aqueous solution (I2 water solution, povidone–iodine, iodine tincture, or Lugol) that contains I2, “iodide” or I− refers to solutions of KI or NaI, and the generic term “iodine” does not identify the specific chemical form of this element.

Discussion

Iodine in normal tissues

Several tissues share with the thyroid gland the capacity to actively accumulate iodine; these include the salivary glands, gastric mucosa, lactating mammary gland, the choroid plexus, ciliary body of the eye, lacrimal gland, thymus, skin, placenta, ovary, uterus, prostate, and pancreas, and they may either maintain or lose this ability under pathological conditions (23). The I− transport system in these extrathyroidal tissues involves the expression of the specific sodium iodide symporter (NIS) and in some cases also pendrin (PDS/SLC26A4) (3). In previous reports, our group demonstrated that the mammary cancer cell line MCF-7 can accumulate both I− and I2, where I− is internalized by NIS (inhibited by KClO4 { perchlorate}), whereas I2 uptake is independent of NIS, PDS, Na+, and energy, but it is saturable and dependent on protein synthesis, suggesting a facilitated diffusion system (24). Moreover, as shown in Figure 1, the thyroid gland, the mammary gland, and the prostate can accumulate both types of iodine, and they are captured by different mechanisms. The thyroid gland, the lactating mammary gland, and the prostate exhibit a significant uptake of I−, which is internalized by NIS (inhibited by KClO4). In the thyroid and the lactating mammary gland, I2 uptake is three times lower than I− uptake, and only about half of the I2 capture is inhibited by KClO4. In contrast, in nubile animals, mammary and prostate tissues captured 300 times less I2 than the thyroid and 4 times less than the lactating mammary gland, and NIS did not participate in its internalization (25). These findings suggest the notion that I2 could contribute to maintaining the normal integrity of these organs. Eskin et al. showed that iodine deficiency alters the structure and function of the mammary gland of virgin rats (26), and that I2 is effective in diminishing ductal hyperplasia and perilobular fibrosis secondary to iodine deficiency. Similarly, I2 treatment (3–6 mg/day) of patients with benign breast disease is accompanied by a significant bilateral reduction in breast size and remission of disease symptoms, effects not observed when I− or protein-bound I− is administered (14,15). Moreover, similar benefits have been found in benign prostatic hyperplasia, in animal models with 0.05% I2 supplementation (17), and in human patients with early benign prostatic hyperplasia (stages I and II) where an 8-month Lugol (5 mg/day) supplement was accompanied by diminished symptoms and prostate-specific antigen values, and an increased urine flow rate (16). All these data agree with epidemiological reports showing a direct association in the Japanese population between the low incidence of breast and prostate pathologies and the moderately high dietary intake of iodine (27–29). Seaweeds, which are widely consumed in Asian countries, contain high quantities of iodine in several chemical forms, that is, I−, I2, and iodate (IO3−); the average iodine consumption in the Japanese population is 1200–5280 μg/day versus 166 and 209 μg/day in the United Kingdom and the United States, respectively (27,30–32). Controversial reports related to algae consumption show that only certain types of seaweed correlated with lower breast cancer incidence in the Korean population (33) or with the presence of higher thyroid cancer (papillary) rates in postmenopausal Japanese women who regularly consumed high quantities of seaweed (10). The authors interpreted these findings as indicating that the iodine content of seaweeds is highly variable or that other components present in the algae, such as arsenic, could also be contributing to the correlation between high seaweed intake and cancer. Nevertheless, in spite of the high nutritional iodine consumption, Asia does not differ from the rest of the world in the prevalence of thyroid disorders (1,28).

Antioxidative effects

Several studies have shown iodine to be a potent antioxidant (34). In the brown algae Laminaria, which contains a 300,000-fold greater iodine concentration than any other living organism, the inorganic iodine acts as an antioxidant, neutralizing hydrogen peroxide in a two-step process, by converting it first to hypoiodous acid and then to water, thereby preventing formation of a hydroxyl radical (35). Similar antioxidant effects have been described in other photosynthetic organisms, and it has been suggested that in some invertebrates a diet of these iodinated organic molecules serves as a “primitive” thyroid gland (36). Berking et al. (37) demonstrated the antioxidant action of I− in polyps of the jellyfish Aurelia aurita, whereas Elstner and co-workers found this antioxidant effect in the rabbit eye (38). Micromolar amounts of I− decrease damage by free oxygen radicals, increase the total antioxidant status in human serum (39,40), and defend brain cells in rats from lipid peroxidation (41). Thyroxine and other iodothyronines act as antioxidants and inhibitors of lipid peroxidation after they are oxidized by hemoglobin and their iodine is released (42,43). I2 supplements decrease lipid peroxidation in normal and tumoral mammary tissues from rats with methylnitrosourea (MNU)-induced mammary cancer (44), and prevent the cardiac damage induced by the antineoplastic agent doxorubicin when I2 (0.05% in drinking water) is administered 2 days before starting the antineoplastic treatment (45). Although the specific mechanisms involved in the antioxidant effect of iodine have not been analyzed in depth, several studies show that I− could be acting directly as an electron donor that quenches free radicals such as OH• or H2O2; alternatively, it may act as a free radical that readily iodinates tyrosine, histidine, and double bonds of some polyunsaturated fatty acids in cellular membranes, making them less reactive with oxygen radicals (46). Figure 2 illustrates the reductive capacity of different chemical forms of iodine in comparison with ascorbic acid, using the in vitro ferric reducing/antioxidant power assay; it shows that I2 exerts a 10- or 50-fold greater antioxidant action than ascorbic acid or KI, respectively.

[...]

Summary and Comments

Animal and human studies have shown that (a) oral administration of I− and I2 exhibits distinct pharmacological and toxicological profiles, where I− is more thyrotoxic than I2, and (b) I2, but not I−, has beneficial effects in both benign and cancer pathologies of organs that are capable of iodine uptake, but only if this element is ingested in milligram amounts. We propose that the International Council for the Control of Iodine Deficiency Disorders considers the importance of these studies and recommend, for pathologies of tissues that take up iodine (primarily thyroid, mammary, and prostate glands and potentially pancreas, gastric, and nervous systems) and under the care of a physician, an iodine intake of at least 3 mg/day in the form of I2.

The "thyrotoxicity" (toxicity to the thyroid gland) in the text above should be taken with a grain of salt.
 
Thank you Gaby for having a look at the images and giving your opinion.

Thank you Laura for the recent post about treating skin conditions with KI.

So, I found an image of cutaneous lymphatic sporotricosis on a finger, which I will attach. I've looked at the other skin conditions (ioderma, bromoderma, etc.) but it doesn't look as much like them.

What confused me is that KI is used to TREAT this condition, but why would taking Lugols bring it out in the first place?

So I've done some searching for links between bromine and fungi and how they might be activated or fed by it and (and maybe this is common knowledge here) I came across this article which briefly mentions how fungi like heavy metals:

_https://rawevolution.wordpress.com/2012/09/08/what-does-hair-loss-iodine-deficiency-and-heavy-metals-have-in-common/

Fungus like organisms, also causes arthritis, in particularly the ligament, joints, and hard collagens, which joins the bones in knees and spinal columns, but fungus and mycoplasma is found to cause hair loss by attacking the hair follies. When the body is high in HEAVY METALS, it becomes a paradise for fungus, mycoplasma and bacteria with fungus abilities. The fungus need food near the heavy metals and the heavy metals protect themselves from hostile antibiotics, so basically antibiotics get destroyed or oxidized in presence of heavy metals. Hmmm, maybe this is the reason why antibiotics doesn’t work!

I've also found this page that says in unusual cases, sporotrichosis may be caused by insect stings:

_http://emedicine.medscape.com/article/1091159-overview

Dermatological Manifestations of Sporotrichosis

[...]

Cutaneous infection often results from a puncture wound involving infected cats, thorns or other plant matter. Other more unusual reported causes include insect stings, squirrel bites, and trauma induced by liposuction.

[...]

Remember I thought it started as a bite? So maybe it's as much the Mercury, Aluminium, etc. being chelated that has caused this reaction in me? That I got bit by something and then there were elevated levels of heavy metals in me that helped the fungus take?

Apart from everything I've read in the LWB and Keto threads, together with the info in this thread, this cellular and pathogenic biology is all a foreign language to me. Does it sound like I'm overreacting and looking for data to support a pre-conceived conclusion?

I'm going to register at the local doctors surgery and see if I can get them to have a look at this lump and hopefully test it for me.
 

Attachments

  • Cutaneous Lymphatic Sporotrichosis.jpg
    Cutaneous Lymphatic Sporotrichosis.jpg
    94.2 KB · Views: 400
Laura said:
And not just in the skin, but throughout the body. When the iodine starts kicking that stuff out, apparently one can get quite sick in a number of ways. My guess is that it is not the iodine or potassium iodide making the person sick, but the displaced/detoxing of the bromides/fluorides. But that can be very problematical!

Perhaps the peeps who get some of these reactions should switch over to potassium iodide and back off the lugol's? They mention several times the "immunomodulatory features" of potassium iodide. Maybe it's the combination of potassium and iodine in the potassium iodide formulation that is key?

It makes sense that purging that crap out of your body can also make you sick/contract skin problems. I wonder if the bromine/fluoride levels in someone correlates to how intense of a purge it can be? When you detox for the first time you're basically clearing your body of all the gunk that has built up to that point, right?

Unless a child's parents are making them take supplements, they probably wont until they're at least in their twenties. Even then it could be well over twenty years before someone detoxes! Releasing twenty years of built up toxins doesn't sound like a cakewalk, but some people may not until their 30s or 40s etc.
 
Laura said:
I was revisiting the sites that deal with potassium iodide used for dermatoligic conditions and thought it might be useful to recap some of that material to see if there are some clues.

Potassium iodide

Potassium iodide (KI) is prepared by reacting iodine with a hot solution of potassium hydroxide. It is mainly used in the form of a saturated solution, 100gm of potassium iodide to 100ml of water. This equates to approximately 50mg/drop. The solution is usually added to water, fruit juice or milk before drinking.

Potassium iodide has been primarily used in the treatment and prevention of simple goitre, which is endemic in areas where the diet is deficient in iodides. Goitre results from low levels of thyroid hormone. Potassium iodide is usually given for this purpose as iodised salt. Other indications include treatment of hyperthyroidism, radiation protectant of the thyroid gland, pre-operative preparation of patients with Graves disease and the treatment of some dermatological conditions such as cutaneous lymphatic sporotrichosis and inflammatory dermatoses.

Potassium iodide for dermatological diseases

It is not clear how potassium idodide works in the treatment of dermatological conditions but it may be because of its effect on neutrophils. Neutrophils are a type of white blood cell, important in the immune system's fight against bacteria.

Potassium iodide appears to be particularly effective in conditions where neutrophils predominate in the early stages of the disease. Its activity against fungi is possibly because it kills the fungi directly or by enhancement of the body's immunologic and non-immunologic defence mechanisms.

The effectiveness of potassium iodide in the treatment of dermatological diseases has been shown in a number of studies.

There is a table that lists conditions and dosage: http://dermnetnz.org/treatments/potassium-iodide.html

In some cases, it's 6 grams a day (!) for up to ten weeks!!!!

SOME people get side effects:

Side effects are rare when potassium iodide is used in short courses and at low doses. The most common side effects are abdominal pain, diarrhoea, nausea or vomiting. These acute side effects often go away during treatment as your body adjusts to the medicine or can be lessened by avoiding rapid dosage increases. Other, less common side effects include urticaria and angioedema, i.e. hives, swelling of arms, face, legs, lips, tongue, throat and lymph glands.

They say there can be issues with "prolonged use" at higher doses. Don't know what "prolonged" means since they've just said that some conditions need up to 10 weeks of treatment at very high doses!!!

I'm thinking I may have to consider trying something along these lines to combat Lymes. I've been on 1 gram for 1 week with no major issues and as depleted as my body would be I dont think I need 1 gram of Iodoral.
I find late at night it feels as if some of the effects wear off and the infections reassert themselves. So I might reduce Iodoral and add SSKI to get to higher dosages much easier.
Those reactions you mention are a little off putting but I think its worth a shot if I at least wipe out the remaining co-infections I have, if not Lymes itself.

As far as detox symptoms go in the last week I've had one significant headache, some diarrhea initially, and a little listless on occasion. There was an increase in one of my Lyme symptoms which is abdominal distension/swelling(picture a guy who looks a few months pregnant for 3 years), but its gone back to what it was before.
Now having a much deeper and well rested sleep and finding it easier to get out of bed.
 
Laura said:
Yas said:
Now, I've just had an idea about why we are getting these symptoms at such a low dose, but maybe I'm totally off track (forgive my brain fog :-[)... Could it be that some critters are being activated by the iodine (as the Cs said) and, besides the detox symptoms, this could be due to a mycoplasma infection that "wakes up" with the lower doses? In that case, what would be the best approach to not wake the infection and, at the same time, not overwhelm the body with a "nuke" dose?

Could very well be. In that case, you might want to do the 6 to 8 drops twice a day for 3 or 4 days to knock it out and then stop for a day or two and do another pulse if needed. Folks here zapped their virus activations in 3 days.

Ok, thank you Laura! I'll wait until the co-factors arrive and try a higher dose.

I think my symptoms are from a virus now. Later on that day I had throat swelling and flu symptoms. My right neck, around the throat, was really tender and it hurt if I touched it. I searched in the cure-zone forum and it seems to be a common symptom too. Nevertheless, while I was telling my dad about it he told me that everyone in the house had a virus recently, which caused this kind of symptoms. My brother said he couldn't even move his neck because it hurt a lot and that he also had ear pain and eyes discomfort. And the whole thing felt just like a bad flu for me (anyway, sometimes it's kind of hard to distinguish between herx and flu). So I was thinking that maybe I got the virus too and it woke up because of the iodine.

Another interesting fact (for me) is that one of my major problems since I can remember was throat swelling. Basically, I always had tonsillitis, doctors wanted to extract them by surgery but my parents refused. It got better after puberty but then I started having sinusitis problems. So I guess that these are sensitive areas for me. And also my skin, so maybe it will be a good idea to order some potassium iodide appart from the Lugol's solution, according to the recent posts about it (very interesting!), because it's good for both respiratory and skin issues.

I stopped taking my Lugol's yesterday and continued with salted water and other supplements, but I took a high dose of Vit C which really helped a lot, but I was super sleepy so I slept a lot too. This morning, I woke up with some more energy, but I still feel pain in the body and general fatigue.

Persej said:
Yas said:
Hi Persej, I really enjoy drinking salted water some with tea and lemon, it tastes like a "tonic water", it could be even better if you put some xylitol or other good (and healthy) sweetener in it.

Salted tea? Which tea?
I could try salted lemonade. For some reason I cannot find xylitol in my country. There is stevia but I'm not big fan of that. But I could try it with salt.

I take it with Ceylon tea, or normal black tea, but not always, most of the time is just plain warm water with salt.

I've read that you lowered the dose and it's better, so I'm glad! :)
 
Thanks Laura, Gaby, and everyone else for all the important info !

I read through what I could in the past few days, and got myself a 60ml bottle of Lugol's solution, although it's only 2% strength. Based on Laura's provided calculations, i'll have to take 120 drops (I multiplied it by 5 since it's only 2%, and Laura based it on 10%) in order to get the minimum benefit of radiation protection. I think i'll start with 30 drops for the first few days, and see how that goes - i plan on ordering some 12% sometime this week, and i'll continue to increase dosage overtime. Im including drinking salt water in the morning (6 grams/ 1 tsp. ), and then 1 hour after each dose of lugols (6 grams / 1 tsp.)

Some of the symptoms ive been struggling with for years (even after switching to a keto diet, supplementing with magnesium and intaking more celtic / himalayan salt) are :

- Chronic Fatigue. I get 7 - 8 hrs sleep but i never feel rested throughout the day.
- Twitching feet if i try to sleep on my back.
- Waking up every two hours, having a smoke, repeat 2 or 3 times a night.
- Irregular sleeping patterns
- Tendency to smoke tobacco alot, (Natural tobacco - not the store bought crap) although I can go hours with a smoke and it doesn't bother me much.
- Chronic low level tension / anxiety
- Daily stupidity (I feel dumb .. All the time. Difficulty reading, focusing, and carrying out tasks)
- Irregular eating patterns, I try to stick with one meal a day, but it's fairly random time of the day. (I mostly just eat pork chops, bacon, eggs, hot chocolates with xylitol, and fishy stuff like salmon, oysters, etc .. i posted about this in the diet section before)
- Easily irratated
-

I have managed to eliminate other stuff that was happening to me, which was a huge help - all thanks to the keto diet. But the rest I have no idea. After reading the transcript, the sott.net article posted by Gaby, and some of this thread, I figure i'll give this a try.

I'll post results when i do a bit more reading and figure out what else i should be supplmenting with the iodine.

Thanks ya'll.
 
Mildain said:
I read through what I could in the past few days, and got myself a 60ml bottle of Lugol's solution, although it's only 2% strength. Based on Laura's provided calculations, i'll have to take 120 drops (I multiplied it by 5 since it's only 2%, and Laura based it on 10%) in order to get the minimum benefit of radiation protection. I think i'll start with 30 drops for the first few days, and see how that goes - i plan on ordering some 12% sometime this week, and i'll continue to increase dosage overtime. Im including drinking salt water in the morning (6 grams/ 1 tsp. ), and then 1 hour after each dose of lugols (6 grams / 1 tsp.)

30 drops of lugol 2% would be something like 75mg of iodine. I would not start with that dose, but with a lower dose (6-12mg), see if detox symptoms are manageable.

More info at: http://www.sott.net/article/307684-Iodine-Suppressed-knowledge-that-can-change-your-life

The synthesized protocol is towards the end of the article. There is also a summary of detox symptoms reported so far.

I would not start with radioprotection doses. Usually potassium iodide is best for that. For some, one single drop of lugol 5% mobilizes enough bromide to deal with.

Hope you have the chance to get more reading done.

Happy reading!
 
Yas said:
I think my symptoms are from a virus now. Later on that day I had throat swelling and flu symptoms. My right neck, around the throat, was really tender and it hurt if I touched it. ... And the whole thing felt just like a bad flu for me (anyway, sometimes it's kind of hard to distinguish between herx and flu).
I don't know if this sounds crazy, but...

What if flu symptoms and Herxheimer reactions are similar because they are actually the same thing? Is it possible that flu symptoms are actually a Herx reaction, and that when the body fights the cells with flu virus, the immune reaction is detoxing those cells?
 
[quote author= Mildain]
Im including drinking salt water in the morning (6 grams/ 1 tsp. ), and then 1 hour after each dose of lugols (6 grams / 1 tsp.) [/quote]

That is an awful lot of salt, Mildain! The iodine protocol calls for 1/4 to 1/3 tsp of salt twice a day, not a full tsp twice a day.

I also use 2.5% Lugol's. I started with 5 drops, one dose in the morning, which is 12.5mg. I got an energy surge and felt a fog had lifted off my head less than an hour later. I am continuing with that dose, and I have just finished week 2. I take the selenium with the Lugol's. An hour or so later, I take 100mg B2 and 500mg B3. What I've noticed, is after the B vitamins, a short time later, I'll feel a heat rise and I will break out in a sweat, but it will pass quickly. I am assuming I am slowly detoxing bromide and hopefully fluoride too.

Thru out, my energy levels have remained good. I drink 3-4 grams of vitamin C powder in water in the evening - which increases urination and also promotes bromide out of the body. I then take NAC and Magnesium before going to bed. I have also used milk thistle extract a few times to help support the liver.

So slow and steady, with tolerable detox reactions that don't upset your daily routine. Also, drink plenty of clean water, which goes without saying, as the detox tends to make you thirsty anyway. The toxins didn't build up in our bodies over night, so we're not going to get rid of them overnight either. 12.5 mg (5 drops of 2% Lugols) is a safe dose to start with. Once the body is saturated with iodine, which at 12.5mg/day, usually takes about a year, you can reduce the dose to maintenance levels (3-5mg/day) and reserve "nuke" levels for specific issues.
 
From what I know about chemistry, the difference between Lugol's and SSKI is similar to how salt helps the protocol.

The halogens are the most reactive because they are short one electron of a full outer valence. So, they tend to strip an electron from other molecules in order to be "stable". Fl Fl- Cl to Cl- and so on.

SSKI is a saturated solution of KI. Inside the water you have K+ and I- ions. This is similar to when you put salt in water, you get Na+ and Cl- ions. This is why salt or other solutions are stable in water and don't precipitate out (unless they are saturated).
(That is also why despite having a lot of iodine, SSKI is clear and not dark.)

The ions make it bind to other things in the body. Perhaps the Bromine, Br- in ionic form gets taken out of the body by being bound to Na+ or the K+. The iodine I- ion takes the place of the bromine Br- ion.

However with Lugol's we have the dark color because there is not just K+ and I- ions but also 'non-ionic' solid mineral Iodine.
If that Iodine replaces a Br- in the body, you have Bromide, but not in ionic form- unlike above where there is a swap of ions.
That's probably why salt helps, to try to get the bromide into a stable solution with a positive ion.

That's also probably why vitamin C solution can turn a bit of lugol's clear and why C also helps. Ascorbic acid- being an acid is full of positive ions. Acids are active with the H+ ions, bases are active with OH- ions. The positive ions of acids would bind to halogens which are negative.

If the Bromide and/or Fluoride is not balanced by a positive ion such as Na or K, it will strip an electron from something else in order to be electrically stable- causing damage, oxidation.
 
Back
Top Bottom